|
Table of Contents
|
Vol 1, 2011 |
| Next Issue | Previous Issue |
Complete PDF for Download (right mouse click) | |
| Issue 1/2011 | |
|---|---|
| Grisold W President's Column: Why Another Journal? pp. 5-6 |
|
| Jellinger KA Early Activities of Brain Tumour Research in Austria: A Historical Note p. 7 |
|
| Kros JM WHO Guidelines for Diagnosis of Glial Tumours: What Is Old and What Is New? PDF Summary pp. 9-12 |
|
| Bello L, Riva M, Casaceli G, Fava E Technological Advances in Glioma Surgery PDF Summary Figures pp. 13-19 |
|
| Hohenegger M Tolerability of Chemotherapy in Elderly Patients PDF Summary pp. 21-24 |
|
| Schlegel U Central Nervous System Toxicity of Chemotherapy PDF Summary Figures pp. 25-29 |
|
| Education: Grant and Fellowship Opportunities from the European Association of Neuro-Oncology p. 31 |
|
| Berghoff A, Furtner J, Wöhrer A, Gatterbauer B, Dieckmann K, Preusser M Management of Brain Metastases: A Case Study PDF Figures pp. 33-34 |
|
| Nowosielski M, Glatzer M, Beer R, Maier H, Stockhammer G A 39-Year-Old Patient with Double Vision and Rapidly Progressing Bulbar Palsy PDF Figures pp. 35-36 |
|
| Soffietti R, Baumert BG, Bello L, Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W Guidelines on the Management of Low-grade Gliomas: EANO Task Force Report pp. 37-44 |
|
| Zwinkels H The Growing Role of Neuro-Oncology Nurses PDF Summary pp. 45-46 |
|
| Oliver K Why Do We Need Brain Tumour Patient Advocates? p. 47 |
|
| Calendar of Events p. 49 |
|
| Short S Congress Report: Trends in Central Nervous System Malignancies pp. 51-52 |
|
| Wick W, Platten M Congress Report: ASCO 2011 - The Neurooncology Perspective pp. 53-54 |
|
| Oberndorfer S National Societies: Austria p. 55 |
|
| Abacioglu U Interview with Dr Martin van den Bent (Rotterdam) about the EORTC CATNON Trial on Grade-3 Gliomas pp. 57-58 |
|
| Weller M Hotspots in Neuro-Oncology p. 59 |
|
| Lang FF, Haynes C SNO News pp. 61-62 |
|